In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Journal of Clinical Investigation

• Publication date

  1981-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI110251PMID 7019246PMCID PMC370801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of exogenous insulin, glucagon, and somatostatin on islet hormone secretion in the perfused chicken pancreas.

  1980cited by this paper
• Regulation of glucagon release: effects of insulin on the pancreatic A2-cell of the guinea pig.

  1979influential reference
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Role of glucagon in the pathogenesis of diabetes: the status of the controversy.

  1978cited by this paper
• Does Insulin Play a Role in the Regulation of its Own Secretion?

  1978cited by this paper
• Inhibition of Insulin Secretion by Exogenous Insulin in Normal Man as Demonstrated by C-peptide Assay

  1978cited by this paper
• Immunoreactive Glucagon Responses to Oral Glucose, Insulin Infusion and Deprivation, and Somatostatin in Pancreatectomized Man

  1978cited by this paper
• Effect of Insulin Therapy on the Profiles of Plasma Immunoreactive Glucagon in Juvenile-type and Adult-type Diabetics

  1978cited by this paper
• Factors controlling gastric-glucagon release.

  1977cited by this paper
• Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man.

  1977cited by this paper
• Intraislet negative insulin-glucagon feedback.

  1976cited by this paper
• Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

  1976cited by this paper
• Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin.

  1976cited by this paper
• Carrier solutions for low-level intravenous insulin infusion.

  1975cited by this paper
• Functional subdivision of islets of Langerhans and possible role of D cells.

  1975cited by this paper
• Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.

  1975cited by this paper
• Glucagon immunoassay using polyethylene glycol to precipitate antibody-bound hormone

  1974cited by this paper
• Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect

  1973cited by this paper
• Glucagon Release from Isolated Pancreas in Streptozotocin-treated Rats

  1973cited by this paper

• Changes in Cells Associated with Insulin Resistance

  2024cites this paper
• Urocortin3 contributes to paracrine inhibition of islet alpha cells in mice.

  2024cites this paper
• Evaluation of mulberry leaves’ hypoglycemic properties and hypoglycemic mechanisms

  2023cites this paper
• Evaluation of plasma cortisol during fasting test in patients with endogenous hyperinsulinemic hypoglycemia. Fifteen years experience.

  2023cites this paper
• Evaluación del cortisol plasmático durante el test de ayuno en pacientes con síndrome hipoglucémico por hiperinsulinismo endógeno. Experiencia de 15 años

  2023cites this paper
• Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion.

  2021cites this paper
• Insulin Resistance: From Mechanisms to Therapeutic Strategies

  2021cites this paper
• The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review

  2021cites this paper
• Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes

  2021cites this paper
• Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats

  2021cites this paper
• DMSO_A_343514 4865..4873

  2021cites this paper
• Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia

  2020cites this paper
• Co-impairment of autonomic and glucagon responses to insulin-induced hypoglycemia in dogs with naturally-occurring insulin-dependent diabetes mellitus.

  2020cites this paper
• The role of α-cells in islet function and glucose homeostasis in health and type 2 diabetes.

  2020cites this paper
• Mechanisms of Insulin Action and Insulin Resistance.

  2018cites this paper
• Insulin Signaling in α-cells Modulates Glucagon Secretion in vivo

  2017cites this paper
• Exploring the molecular mechanisms underlying α- and β-cell dysfunction in diabetes

  2017cites this paper
• Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells

  2017cites this paper
• Relations intercellulaires dans les îlots de Langerhans et leur rôle dans la sécrétion du glucagon

  2017cites this paper
• Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation

  2016cites this paper
• Chapter 32 – Insulin Secretion

  2016cites this paper
• Short-term diabetic hyperglycemia suppresses celiac ganglia neurotransmission, thereby impairing sympathetically mediated glucagon responses.

  2015cites this paper
• miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development

  2015cites this paper
• Dual‐hormone treatment with insulin and glucagon in patients with type 1 diabetes

  2015cites this paper
• Physiological and pathophysiological control of glucagon secretion by pancreatic α-cells

  2015cites this paper
• MOLECULE PAGE GLUCAGON

  2013cites this paper
• Pathophysiology of diabetes mellitus type 2: beyond the duo "insulin resistance-secretion deficit".

  2013cites this paper
• Novel function of transthyretin in pancreatic alpha cells

  2012cites this paper
• Glucotoxicity and α Cell Dysfunction: Involvement of the PI3K/Akt Pathway in Glucose-Induced Insulin Resistance in Rat Islets and Clonal αTC1-6 Cells

  2012cites this paper
• Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes

  2012cites this paper
• Isosteviol Has Beneficial Effects on Palmitate-Induced α-Cell Dysfunction and Gene Expression

  2012cites this paper
• Diabetes - Damages and Treatments

  2011cites this paper
• Growth factor signalling in the regulation of α‐cell fate

  2011cites this paper
• Molecular Mechanism Underlying the Intra-Islet Regulation of Glucagon Secretion

  2011influential citation
• CHAPTER 31 – Type 2 Diabetes Mellitus

  2011cites this paper
• The Physiology of Glucagon

  2010cites this paper
• Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction.

  2010cites this paper
• Glucagon Secreting Cells Responds to Insulin Secretion In vitro Using Immunocytochemistry

  2010cites this paper
• Native pancreatic α‐cell adaptation in streptozotocin‐induced diabetic primates: importance for pig islet xenotransplantation

  2009cites this paper
• Insulin signaling in alpha cells modulates glucagon secretion in vivo.

  2009cites this paper
• Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.

  2009cites this paper
• Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.

  2009cites this paper
• Insulin modulation of glucagon secretion: The role of insulin and other factors in the regulation of glucagon secretion

  2009cites this paper
• Hypothalamic control of hepatic glucose production and its potential role in insulin resistance.

  2008cites this paper
• DYNAMIC MODELING OF FREE FATTY ACID, GLUCOSE, AND INSULIN DURING REST AND EXERCISE IN INSULIN DEPENDENT DIABETES MELLITUS PATIENTS

  2008cites this paper
• The mechanisms that underlie glucose sensing during hypoglycaemia in diabetes

  2008cites this paper
• A KATP Channel-Dependent Pathway within α Cells Regulates Glucagon Release from Both Rodent and Human Islets of Langerhans

  2007cites this paper
• Functional imaging of the pancreas: the role of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy.

  2007cites this paper
• The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children

  2007cites this paper
• Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies

  2007cites this paper
• Development of the pancreas and neonatal diabetes

  2007cites this paper
• The Inhibitory Effects of Insulin on Hepatic Glucose Production Are Both Direct and Indirect

  2006cites this paper
• Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic α-Cells*

  2005cites this paper
• Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans.

  2005cites this paper
• Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development?

  2005cites this paper
• Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells.

  2005cites this paper
• Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes.

  2004cites this paper
• Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the "switch-off" hypothesis.

  2004cites this paper
• A Reappraisal of the Blood Glucose Homeostat which Comprehensively Explains the Type 2 Diabetes Mellitus–Syndrome X Complex

  2003influential citation
• The Zone Diet Phenomenon: A Closer Look at the Science behind the Claims

  2003cites this paper
• Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy.

  2003cites this paper
• Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.

  2002cites this paper
• AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat.

  2002cites this paper
• Differential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic mice.

  2002cites this paper
• glucagon secretion in the Diabetic BB Rat

  2002cites this paper
• Glucagon and Glucagon‐like Peptide Production and Degradation

  2001cites this paper
• Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs.

  2001cites this paper
• Insulin and Glucagon Secretion in vivo and its Neural Control

  2001cites this paper
• Effect of pancreatic transplantation on counterregulatory hormonal responses to hypoglycaemia

  1999cites this paper
• Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.

  1999cites this paper
• Perspectives in Diabetes Autonomic Mediation of Glucagon Secretion During Hypoglycemia Implications for Impaired -Cell Responses in Type 1 Diabetes GLUCAGON SECRETION DURING HYPOGLYCEMIA:

  1998influential citation
• Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes.

  1998cites this paper
• Counterregulatory Hormones: Molecular, Biochemical, and Physiologic Aspects

  1998cites this paper
• Autocrine/Paracrine Intermediates in Hormonal Action and Modulation of Cellular Responses to Hormones

  1997cites this paper
• Glucose homeostasis with infinite gain: further lessons from the Daisyworld parable?

  1997cites this paper
• Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation.

  1996cites this paper
• A Comparison of the Effects of Selective Increases in Peripheral or Portal insulin on Hepatic Glucose Production in the Conscious Dog

  1996cites this paper
• Insulin inhibits secretin-stimulated pancreatic bicarbonate output by a dose-dependent neurally mediated mechanism.

  1996cites this paper
• Microcirculation of the Islets of Langerhans: Long Beach Veterans Administration Regional Medical Education Center Symposium

  1996cites this paper
• Exogenous insulin dose-dependently suppresses glucopenia-induced glucagon secretion from perfused rat pancreas.

  1995cites this paper
• Suppression of insulin secretion by C-peptide infusion in humans.

  1995cites this paper
• Pulsatile Administration of Insulin and Glucagon in Man

  1994cites this paper
• Hyperinsulinemia Decreases Second-Phase But Not First-Phase Arginine-Induced Insulin Release in Humans

  1994cites this paper
• Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.

  1993cites this paper
• Evidence that suppression of insulin secretion by insulin itself is neurally mediated.

  1993cites this paper
• per se but not normoinsulinemia is responsible endogenous insulin secretion after oral glucose load in NIDDM

  1992cites this paper
• Effect of physiological hyperinsulinemia on counterregulatory hormone responses during hypoglycemia in humans.

  1992cites this paper
• Effect of glucose infusion in dogs on blood sugar, insulinemia and serum free fatty acid responses.

  1992cites this paper
• Normoglycemia per se but not normoinsulinemia is responsible for suppressing endogenous insulin secretion after oral glucose load in NIDDM.

  1992cites this paper
• Morphological changes in the human endocrine pancreas induced by chronic excess of endogenous glucagon

  1991cites this paper
• Counterregulatory adaptation to recurrent hypoglycemia in normal humans.

  1991cites this paper
• Failure of chronic hyperinsulinemia to suppress pancreatic glucagon in vivo in the rat.

  1991cites this paper
• Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic Alpha cells

  1991cites this paper
• Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma.

  1991cites this paper
• A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man.

  1991cites this paper
• Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp.

  1991cites this paper
• Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes.

  1990cites this paper
• Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.

  1990cites this paper
• Responses of the pancreatic A cell during hypoglycemia and hyperglycemia are dependent on the B cell.

  1989cites this paper
• Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.

  1989cites this paper